The Discounted Cash Flow (DCF) valuation of Turning Point Therapeutics Inc (TPTX) is (22,441.98) USD. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on DCF is -29625.0%.
Based on the latest price of 76.01 USD and our DCF valuation, Turning Point Therapeutics Inc (TPTX) is a sell. selling TPTX stocks now will result in a potential gain of 29625.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.5% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (87,979.04) - (12,929.77) | (22,441.98) |
| Upside | -115846.7% - -17110.6% | -29625.0% |